Jiangsu wuzhong(SH:600200) Shang Hai Zheng Quan Bao·2025-12-10 18:49Core Viewpoint - Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. is entering a delisting period due to continuous false disclosures in annual reports from 2020 to 2023, leading to a decision by the Shanghai Stock Exchange to terminate its stock listing [2][4]. Group 1: Delisting Announcement - The company received a self-regulatory decision from the Shanghai Stock Exchange on December 1, 2025, stating that its stock will be delisted due to major violations of listing rules [4][6]. - The trading period for the delisting will start on December 9, 2025, lasting for 15 trading days, with the last trading day expected to be December 29, 2025 [6][7]. - The stock will be traded on the risk warning board of the Shanghai Stock Exchange during the delisting period, with no price limit on the first trading day and a daily limit of 10% thereafter [5][7]. Group 2: Trading and Risk Management - Investors are advised to settle any stock pledge repurchase, agreed repurchase, margin financing, and other related transactions before the stock is delisted [4][8]. - The company will not plan or implement any major asset restructuring during the delisting period [7][8]. - Personal investors must have over 24 months of trading experience and maintain an average asset of over 500,000 RMB in their accounts to buy delisting stocks [7].